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Editorial
Goals, globalization and the impact factor of the journal
Milton Artur Ruiz*
Editor-in-chief of Revista Brasileira de Hematologia e Hemoterapia (RBHH), São José do Rio Preto, SP, Brazil
Over the years, as editors of Revista Brasileira de Hematologia 
e Hemoterapia (RBHH), we have faced different issues. The first 
of these, an observation that sometimes became a question, is 
about the purpose of the journal.
To answer this question it is necessary to return to the 
journal’s origins in the 1980s. In those difficult times of 
discretion, Brazil was different and the Sociedade Brasileira 
de Hematologia e Hematologia (SBHH) was going through 
a period of restructuring and controversy about the role of 
hemotherapy in the country. In a firm and decisive action, 
remunerated blood donation was banned in Brazil. The SBHH 
had published a monthly newsletter since 1973 which aimed to 
promote the activities of the Executive Board of the society and 
informing everyone about what was going on in hematology 
and transfusion medicine across the country. At a time when 
there was little information, when for most it was difficult to 
access scientific journals, it was said that for some corners of 
the country, this was the only accessible communication about 
hematology and transfusion medicine.
An international congress of hematology was hosted by the 
city of Buenos Aires, Argentina, in 1984 when the Board of the 
SBHH, in a daring act involving four or five people, modified the 
format of the newsletter and launched instead a prototype of 
the scientific journal that circulated during the event. At that 
point the primary objective and heresy of the creators was 
to move forward and to mark a scientific position, a criticism 
that the SBHH received, in addition to attracting young people 
to the society. Today, thinking about it, many people might 
consider that act as conceited, as a sign of progress in Brazilian 
hematology, to have a journal of its own as there were none 
in Brazil or even in any South America country. The journal 
of hematology for all the other societies in this area in Latin 
America was Sangre, from Barcelona. After being published in 
Spanish for forty years, Sangre stopped to circulate in 1999.
After a shaky start, the journal of the SBHH became effective 
two years after its first edition was indexed in the extinct Index 
Médico Latino Americano (IMLA); soon after, it was included in 
the Literatura Latino Americana de Ciências da Saúde e do Caribe 
database (Lilacs). From then on there was no turning back 
and the successive Executive Boards have always had as their 
main goal to publish the national option on hematology and 
transfusion medicine; this culminated with changes that led 
to the current title. So the journal slowly became a depository 
for publications of authors across the country, the results of 
dissertations and doctorate theses, of information relevant 
to Brazil, and mainly for works that would probably never 
be accepted for publication in foreign journals. Submissions 
until then had basically been limited to the states of Rio de 
Janeiro and São Paulo but with this change there was an 
increase in the numbers of contributions from every state in 
the country.1 In order to illustrate this, I will mention subject 
matters such as the damaging effect of the fortification of 
flour with iron,2,3 Dengue fever,4-8 the compassionate use of 
cell therapy in the country,9 articles on the Associação Médica 
Brasileira (AMB) and Associação Brasileira de Hematologia, 
Hemoterapia e Terapia Celular (ABHH) guidelines project10-14 
and many others of scientific and national interest that were 
published and had a great impact. I endorse this and ask the 
readers a question: would the themes mentioned be accepted 
by a journal published in another country?
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From the beginning, the journal always aimed to be the 
official representative of Brazilian hematology and transfusion 
medicine. Today, this goal continues, but the visibility of 
Brazilian production was also added, with the change to 
publishing in English and indexing it in important international 
databases such as Scopus and PubMed. To achieve this, the 
journal needed to progress, with great improvements in its 
editing, in particular, with the choice to publish in English, 
the lingua franca of communication. One major contribution 
of the journal is in education as it has provided guidance to 
authors, urging them to improve their scientific papers in 
order to increase their chances of publishing in the RBHH 
and, in the future, in all other scientific periodicals. Nowadays 
in the RBHH all contributions are assessed by the Internal 
Review Board in respect to the format, the English and the 
statistical analyses before being assessed by experts on the 
merit of the submission. With these measures the rejection 
rate has increased dramatically, but the editorial policy and 
the primary objectives have been preserved.15 And to think 
that five years ago there was an attempt to close the journal; 
it remains due to its history and to the work of many past and 
present hematologists.
Internationalization of the journal
In addition to the measures already mentioned, such as being 
published in English, the Editorial Board was changed a few 
years ago with several foreigners being invited to participate. 
Albeit an important step, this, in itself, does not make 
the RBHH international as its contents, so far, are almost 
exclusively from Brazil, despite efforts over the last three 
years including personal invitations to obtain contributions 
from foreign authors. Summarizing, the RBHH is a publication 
edited in a non-anglophone country, Brazil, representative of 
Brazilian scientific institutions (ABHH, Sociedade Brasileira 
de Transplantes de Medula Óssea [SBTMO], Associação Italo-
Brasileira de Hematologia [AIBE] and Sociedade Brasileira 
de Oncologia Pediátrica [SOBOPE]), it publishes almost 
exclusively Brazilian papers and, in general, is executively 
and scientifically controlled by Brazilians and so this is not an 
international journal.16 Will it one day be international?
The impact factor of the journal
We define impact as a measurement of the repercussion of an 
article or some knowledge published by a determined scientific 
journal, that is, how it influences and makes a difference to the 
community that it covers. This can be measured by means of 
reading, use and application of knowledge, chiefly represented 
by citations in other published articles, which symbolize 
the level of interest of other researchers and recognize the 
quality of information.17 In order to rank scientific journals 
from various fields of knowledge, a bibliometric index was 
created by Garfield comparing the number of citations of 
a journal obtained in the universe of journals with the 
number of publications in the journal, all within a certain 
period of time. However when asked, the aim is to know the 
importance and the rank of a particular scientific journal. 
Thus arose the impact factor (IF) of the Institute for Scientific 
Information (ISI) that, since 1955, reports every year a list of 
the classification of journals in the Journal Citation Report 
(JCR), within the universe of journals in its charge.17,18 The 
IF does not aim to evaluate the quality or qualification of 
authors.18,19 However interest in the IF in academic circles 
increased with the reclassification of journals by the Qualis 
system of the Coordenação de Aperfeiçoamento de Pessoal de Nível 
Superior (CAPES) that privileges journals according to their 
IF (ISI, JCR, Thomson Reuters). Following this, the evaluation 
of postgraduate programs and evaluations comparing 
researchers went on to grade scientific publications using 
these criteria thus generating controversy until today.20,21 
The two- or three-year IF is a useful bibliometric index; it 
has variations according to the universe of journals covered 
with the largest number today being indexed to Scopus or 
Google. In our area, the Scientific Electronic Library Online 
(SciELO) Brazil collection offers the IF and other indexes 
and recently announced the new SciELO Citation Index in 
partnership with Thomson Reuters. Another evaluation index 
for journals is the Scimago Journal Rank (SJR). Other indices 
exist including the index of immediacy, and the H index, with 
all being relevant and helping in the evaluation of journals, 
but with imperfections and dissatisfaction.21 Hence, altimetry 
appeared as an alternative to the traditional bibliometric 
indices and H index in the midst of this dissatisfaction 
with evaluations using traditional scientific scientometric 
assessments, and after behavioral changes reflecting the rise 
of the internet and the electronic availability of every journal. 
Altimetry sets out to assess the impact as in its definition16 
measuring the complete range of repercussions of articles, 
data and scientific information cited in the lay media, in print 
and electronic media, and as viewings (internet site visits), 
downloads, endorsements in the social media and new media, 
and as an influence to change government policies.2,3
In conclusion, the journal aims to be the foremost journal 
of hematology, transfusion medicine and cellular therapy of 
Brazil. It aims not to stray from this goal after gaining visibility 
and indexing in all the major databases in the world.
The journal is not an international journal, but has the 
ambition of becoming better known throughout the world.
The journal has an impact factor in databases and has 
applied to be included in the JCR/ISI/Thomson Reuters IF; it 
is widely available electronically and entered in the world 
publishing market to progress with a new website and a 
contract with an internationally renowned publisher.
The journal depends on the editors as the guardians of its 
progress in order to avoid ‘elitization’ and deviations from the 
goals that it has had since its inception.
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